Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

58 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Association between well-characterized lung cancer lncRNA polymorphisms and platinum-based chemotherapy toxicity in Chinese patients with lung cancer.
Gong WJ, Peng JB, Yin JY, Li XP, Zheng W, Xiao L, Tan LM, Xiao D, Chen YX, Li X, Zhou HH, Liu ZQ. Gong WJ, et al. Acta Pharmacol Sin. 2017 Apr;38(4):581-590. doi: 10.1038/aps.2016.164. Epub 2017 Mar 6. Acta Pharmacol Sin. 2017. PMID: 28260796 Free PMC article.
Genetic variations of Omi/HTRA2 in Chinese patients with Parkinson's disease.
Wang CY, Xu Q, Weng L, Zhang Q, Zhang HN, Guo JF, Tan LM, Tang JG, Yan XX, Tang BS. Wang CY, et al. Brain Res. 2011 Apr 18;1385:293-7. doi: 10.1016/j.brainres.2011.02.037. Epub 2011 Feb 19. Brain Res. 2011. PMID: 21338583
Lower serum UA levels in Parkinson's disease patients in the Chinese population.
Zhang HN, Guo JF, He D, Lei LF, Wang YQ, Wang CY, Tan LM, Yan XX, Shen L, Tang BS. Zhang HN, et al. Neurosci Lett. 2012 Apr 18;514(2):152-5. doi: 10.1016/j.neulet.2012.02.077. Epub 2012 Mar 3. Neurosci Lett. 2012. PMID: 22405811
Rho GTPases: RAC1 polymorphisms affected platinum-based chemotherapy toxicity in lung cancer patients.
Zou T, Yin J, Zheng W, Xiao L, Tan L, Chen J, Wang Y, Li X, Qian C, Cui J, Zhang W, Zhou H, Liu Z. Zou T, et al. Cancer Chemother Pharmacol. 2016 Aug;78(2):249-58. doi: 10.1007/s00280-016-3072-0. Epub 2016 Jun 14. Cancer Chemother Pharmacol. 2016. PMID: 27299748 Clinical Trial.
Circulating resistin levels and obesity-related cancer risk: A meta-analysis.
Gong WJ, Zheng W, Xiao L, Tan LM, Song J, Li XP, Xiao D, Cui JJ, Li X, Zhou HH, Yin JY, Liu ZQ. Gong WJ, et al. Oncotarget. 2016 Sep 6;7(36):57694-57704. doi: 10.18632/oncotarget.11034. Oncotarget. 2016. PMID: 27509174 Free PMC article.
Genetic Polymorphisms and Platinum-based Chemotherapy Treatment Outcomes in Patients with Non-Small Cell Lung Cancer: A Genetic Epidemiology Study Based Meta-analysis.
Tan LM, Qiu CF, Zhu T, Jin YX, Li X, Yin JY, Zhang W, Zhou HH, Liu ZQ. Tan LM, et al. Sci Rep. 2017 Jul 17;7(1):5593. doi: 10.1038/s41598-017-05642-0. Sci Rep. 2017. PMID: 28717179 Free PMC article.
CLEC4M is associated with poor prognosis and promotes cisplatin resistance in NSCLC patients.
Tan LM, Li X, Qiu CF, Zhu T, Hu CP, Yin JY, Zhang W, Zhou HH, Liu ZQ. Tan LM, et al. J Cancer. 2019 Oct 19;10(25):6374-6383. doi: 10.7150/jca.30139. eCollection 2019. J Cancer. 2019. PMID: 31772670 Free PMC article.
58 results
Jump to page